Skip to main content
OpenTrials

Clinical trial condition

Parkinsonian Disorders

Explore clinical trials studying Parkinsonian Disorders. Study availability and eligibility vary by location and protocol.

3,333 public trials 612 recruiting studies
Refine in advanced search Browse all conditions

Parkinsonian Disorders trial results

Completed

Sleep, Awake & Move - Part II

NCT02710487

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Sleep and Epilepsy center Department of Neurology, Neurocenter of Southern Switzerland Lugano, Switzerland
View Trial Details
Completed

FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)

NCT03170063

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Oregon Health and Sciences University Portland, Oregon, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528

NCT01536574

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Wuhan, Hubei, China
  • GSK Investigational Site Suzhou, Jiangsu, China
  • GSK Investigational Site Xi'an, Shaanxi, China
View all 18 locations
View Trial Details
Completed

Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

NCT01777555

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Civitas Investigational Site 1013 Little Rock, Arkansas, United States
  • Civitas Investigational Site 1004 Boca Raton, Florida, United States
  • Civitas Investigational Site 1002 Port Charlotte, Florida, United States
  • Civitas Investigational Site 1015 Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa

NCT01154166

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Wuhan, Hubei, China
  • GSK Investigational Site Suzhou, Jiangsu, China
  • GSK Investigational Site Xi'an, Shaanxi, China
View all 18 locations
View Trial Details

Related conditions